128 related articles for article (PubMed ID: 1524919)
21. The use of adjuvant chemotherapy for breast cancer in a community practice.
Rosenberg A; Winer EP; Cadman E
Conn Med; 1985 May; 49(5):281-5. PubMed ID: 3839177
[No Abstract] [Full Text] [Related]
22. Clinical and pathological response to primary chemotherapy in operable breast cancer.
Chollet P; Charrier S; Brain E; Curé H; van Praagh I; Feillel V; de Latour M; Dauplat J; Misset JL; Ferrière JP
Eur J Cancer; 1997 May; 33(6):862-6. PubMed ID: 9291806
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemotherapy in locally advanced breast cancer.
Singh G; Singh DP; Gupta D; Muralikrishna BV
J Surg Oncol; 1996 Jan; 61(1):38-41. PubMed ID: 8544458
[TBL] [Abstract][Full Text] [Related]
24. Role of adjuvant chemotherapy in male breast cancer.
Patel HZ; Buzdar AU; Hortobagyi GN
Cancer; 1989 Oct; 64(8):1583-5. PubMed ID: 2676137
[TBL] [Abstract][Full Text] [Related]
25. [A comparative study of 4 sequential first-line chemotherapy protocols in locally advanced breast cancer].
Ferrero JM; Namer M; Dufour JF; Largillier R; Creisson A; Teissier E; Machiavello JC; Lallement M; Monticelli J; Abbes M
Bull Cancer; 1997 Jan; 84(1):10-6. PubMed ID: 9180853
[TBL] [Abstract][Full Text] [Related]
26. The role of surgery in the combined treatment of locally advanced breast cancer.
Canavese G; Catturich A; Battistini G; Caroti C; Pronzato P; Gardin G; Amoroso D; Bertelli G; Conte PF; Tomao S
Oncology; 1989; 46(6):353-6. PubMed ID: 2587002
[TBL] [Abstract][Full Text] [Related]
27. Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer.
Semiglazov VF; Topuzov EE; Bavli JL; Moiseyenko VM; Ivanova OA; Seleznev IK; Orlov AA; Barash NY; Golubeva OM; Chepic OF
Ann Oncol; 1994 Sep; 5(7):591-5. PubMed ID: 7993833
[TBL] [Abstract][Full Text] [Related]
28. Role of chemotherapy in acute breast cancer. Analysis of 41 cases.
Calderoli H; de Manzini N; Keiling R
Int Surg; 1988; 73(2):112-5. PubMed ID: 3397256
[TBL] [Abstract][Full Text] [Related]
29. Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial.
Robidoux A; Tang G; Rastogi P; Geyer CE; Azar CA; Atkins JN; Fehrenbacher L; Bear HD; Baez-Diaz L; Sarwar S; Margolese RG; Farrar WB; Brufsky AM; Shibata HR; Bandos H; Paik S; Costantino JP; Swain SM; Mamounas EP; Wolmark N
Lancet Oncol; 2013 Nov; 14(12):1183-92. PubMed ID: 24095300
[TBL] [Abstract][Full Text] [Related]
30. CMF + radiotherapy in the primary treatment of operable breast cancer: preliminary results of a phase II pilot study.
Bellantone R; Lombardi CP; Cefaro GA; Nardone L; Rossi S; Minelli S; Raffaelli M; Crucitti F
J Surg Oncol; 1998 May; 68(1):48-50. PubMed ID: 9610663
[TBL] [Abstract][Full Text] [Related]
31. Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099.
Alvarez RH; Booser DJ; Cristofanilli M; Sahin AA; Strom EA; Guerra L; Kau SW; Gonzalez-Angulo AM; Hortobagyi GN; Valero V
Cancer; 2010 Mar; 116(5):1210-7. PubMed ID: 20082452
[TBL] [Abstract][Full Text] [Related]
32. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
[TBL] [Abstract][Full Text] [Related]
33. Primary medical (neo-adjuvant) chemotherapy for operable breast cancer.
Smith IE; Jones AL; O'Brien ME; McKinna JA; Sacks N; Baum M
Eur J Cancer; 1993; 29A(12):1796-9. PubMed ID: 8398318
[TBL] [Abstract][Full Text] [Related]
34. Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure.
Rose MA; Henderson IC; Gelman R; Boyages J; Gore SM; Come S; Silver B; Recht A; Connolly JL; Schnitt SJ
Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):711-7. PubMed ID: 2777660
[TBL] [Abstract][Full Text] [Related]
35. Surgical adjuvant chemotherapy for breast cancer: a comparison of CMF and CAF regimens.
Babar AM
J Pak Med Assoc; 1991 Dec; 41(12):293-6. PubMed ID: 1824559
[TBL] [Abstract][Full Text] [Related]
36. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
38. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
Kuerer HM; Sahin AA; Hunt KK; Newman LA; Breslin TM; Ames FC; Ross MI; Buzdar AU; Hortobagyi GN; Singletary SE
Ann Surg; 1999 Jul; 230(1):72-8. PubMed ID: 10400039
[TBL] [Abstract][Full Text] [Related]
39. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
[TBL] [Abstract][Full Text] [Related]
40. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.
Sataloff DM; Mason BA; Prestipino AJ; Seinige UL; Lieber CP; Baloch Z
J Am Coll Surg; 1995 Mar; 180(3):297-306. PubMed ID: 7874340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]